<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2021.770821</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Profiling the Quality and Quantity of Naturally Induced Antibody Responses Against Pfs230 and Pfs48/45 Among Non-Febrile Children Living in Southern Ghana: A Longitudinal Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Broni</surname>
<given-names>Fermin K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1503263"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Acquah</surname>
<given-names>Festus K.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1387344"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Obiri-Yeboah</surname>
<given-names>Dorcas</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/926705"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Obboh</surname>
<given-names>Evans K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarpong</surname>
<given-names>Esther</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1531247"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Amoah</surname>
<given-names>Linda E.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1266099"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast</institution>, <addr-line>Cape Coast</addr-line>, <country>Ghana</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Immunology Department, Noguchi Memorial Institute for Medical Research, University of Ghana</institution>, <addr-line>Accra</addr-line>, <country>Ghana</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>West African Centre for Cell Biology of Infectious Pathogens, University of Ghana</institution>, <addr-line>Accra</addr-line>, <country>Ghana</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Directorate of Research, Innovation and Consultancy, University of Cape Coast</institution>, <addr-line>Cape Coast</addr-line>, <country>Ghana</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Molecular Biology and Biotechnology, School of Biological Sciences, University of Cape Coast</institution>, <addr-line>Cape Coast</addr-line>, <country>Ghana</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Brice Rotureau, Institut Pasteur, France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Celia Dechavanne, IRD UMR216 M&#xe8;re et enfant face aux infections tropicales (MERIT), France; Abhai K. Tripathi, Johns Hopkins University, United States; James Kazura, Case Western Reserve University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Linda E. Amoah, <email xlink:href="mailto:lek.amoah@gmail.com">lek.amoah@gmail.com</email>; <email xlink:href="mailto:lamoah@noguchi.ug.edu.gh">lamoah@noguchi.ug.edu.gh</email>
</p>
</fn>
<fn fn-type="equal" id="fn002">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>11</volume>
<elocation-id>770821</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Broni, Acquah, Obiri-Yeboah, Obboh, Sarpong and Amoah</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Broni, Acquah, Obiri-Yeboah, Obboh, Sarpong and Amoah</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>A clear understanding of the properties of naturally induced antibody responses against transmission-blocking vaccine candidates can accelerate the understanding of the development of transmission-blocking immunity. This study characterized the naturally induced IgG responses against two leading transmission-blocking vaccine antigens, Pfs230 and Pfs48/45, in non-febrile children living in Simiw, Ghana. Consecutive sampling was used to recruit 84 non-febrile children aged from 6 to 12 years old into the 6-month (November 2017 until May 2018) longitudinal study. Venous blood (1 ml) was collected once every 2 months and used to determine hemoglobin levels, <italic>P. falciparum</italic> prevalence using microscopy and polymerase chain reaction, and the levels and relative avidity of IgG responses against Pfs230 and Pfs48/45 using indirect ELISA. IgG levels against Pfs230 and Pfs48/45 decreased from the start (November) to the middle (January) and end (March) of the dry season respectively, then they began to increase. Participants, especially older children (10&#x2013;12 years old) with active infections generally had lower antibody levels against both antigens. The relative avidities of IgG against both antigens followed the trend of IgG levels until the middle of the dry season, after which the relative avidities of both antigens correlated inversely with the antibody levels. In conclusion, although IgG antibody levels against both Pfs48/45 and Pfs230 began to increase by the early rainy season, they were inversely correlated to their respective relative avidities.</p>
</abstract>
<kwd-group>
<kwd>antibody levels</kwd>
<kwd>relative avidity</kwd>
<kwd>gametocyte</kwd>
<kwd>
<italic>P. falciparum</italic>
</kwd>
<kwd>polymerase chain reaction (PCR)</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="41"/>
<page-count count="12"/>
<word-count count="5686"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The cycle of malaria transmission can be broken by the development of an immune response that arrests the progress of the infectious stages of the parasite, including gametocytes. <italic>Plasmodium falciparum</italic> antigens Pfs230 and Pfs48/45 are among the most widely characterized gametocyte surface proteins (<xref ref-type="bibr" rid="B10">Arredondo et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B22">Jones et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">MacDonald et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B3">Acquah et&#xa0;al., 2017</xref>). The Pfs230 is a 3,135 amino acid (aa) protein containing 14 s48/45 6-Cys domains (<xref ref-type="bibr" rid="B41">Williamson &amp; Kaslow, 1993</xref>) and Pfs48/45 is a 448 aa protein containing 3 s48/45 6-Cys domain (<xref ref-type="bibr" rid="B33">Outchkourov et&#xa0;al., 2008</xref>). Antibodies against both Pfs230 and Pfs48/45 antigens possess transmission-reducing activities and are thus able to prevent the completion of the sporogonic life cycle of the malaria parasite within the mosquito vector (<xref ref-type="bibr" rid="B23">Kumar et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B13">Bousema et&#xa0;al., 2006</xref>). Enhanced knowledge of the properties of naturally induced antibody responses against these antigens can help accelerate the understanding of malaria transmission-blocking vaccine (MTBV) candidate development. Children have been identified to efficiently harbor gametocytes (<xref ref-type="bibr" rid="B24">Lamptey et&#xa0;al., 2018</xref>) and make them a relevant group to study the quality (avidity) and quantity (level) of naturally induced IgG responses against gametocyte antigens.</p>
<p>Although there are a number of different antibody types, IgG and IgM occurred to be the most commonly examined types (<xref ref-type="bibr" rid="B25">Leoratti et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B42">Zakeri et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B28">Mayor et&#xa0;al., 2018</xref>) which have also been found to keep a <italic>P. falciparum</italic> infection under control (<xref ref-type="bibr" rid="B15">Dodoo et&#xa0;al., 2008</xref>). Usually, an encounter between a B cell and parasite antigen activates the B cell with the help of T cell, to proliferate and differentiate into plasma cells. Plasma cells then release IgM primarily and IgG secondarily into circulation (<xref ref-type="bibr" rid="B4">Alam et&#xa0;al., 2013</xref>), binding to the target antigen. In many instances, repeated exposure of a B cell to the same antigen results in an increase in the total bond strength of the antibody-antigen complex (avidity) (<xref ref-type="bibr" rid="B20">Howitt et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B29">Murugan et&#xa0;al., 2018</xref>).</p>
<p>Protection against <italic>P. falciparum</italic> parasites is known to be associated with high antibody avidity rather than just high antibody levels (<xref ref-type="bibr" rid="B12">Bachmann et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B35">Ross et&#xa0;al., 2001</xref>). However, in some instances, high antibody levels have been found to compensate for low antibody avidity and maintain an individual&#x2019;s acquired immunity (<xref ref-type="bibr" rid="B38">Ssewanyana et&#xa0;al., 2017</xref>). The immunity that results from repeated exposure to the sexual stages of the malaria parasite (malaria transmission-blocking immunity) can prevent the mosquito from becoming infectious and thus reduce malaria transmission rather than protect the individual directly (<xref ref-type="bibr" rid="B19">Healer et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B40">White et&#xa0;al., 2018</xref>).</p>
<p>This study sought to characterize the properties (levels and relative avidities) of naturally-induced antibody responses against two transmission-blocking vaccine candidates, Pfs230 and Pfs48/45 among non-febrile children in southern Ghana.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Ethics, Study Site, Population, and Sampling</title>
<p>Ethical clearance for this study (NMIR-IRB CPN 024/14-15) was obtained from the Institutional Review Board (IRB) of Noguchi Memorial Institute for Medical Research (NMIMR). Written informed consent was obtained before enrolling participants for this study.</p>
<p>The study was conducted in Simiw (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>); a peri-urban community in the Komenda&#x2013;Edina&#x2013;Eguafo&#x2013;Abrem (KEEA) Municipal Assembly of the Central Region of Ghana. Malaria transmission in Simiw is usually perennial and overlaps with the rainy season peaking in-between May and July. The dry season however begins in November and ends in April (<xref ref-type="bibr" rid="B2">Acquah et&#xa0;al., 2020</xref>). Study participants were pupils of the Simiw M/A Basic School-aged from 6 to 12 years.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>A map of Ghana showing the study site (Simiw) in the enlarged area. The map was generated using Google maps.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-770821-g001.tif"/>
</fig>
<p>A total volume of 1 ml of the venous blood sample was collected from each of the 84 study participants once every 2 months beginning November 2017 until May 2018. Prior to sample collection, the axillary temperature was measured using a digital thermometer. Thick and thin smears were prepared according to WHO guidelines (<xref ref-type="bibr" rid="B31">Organization, 2016</xref>). Hemoglobin levels were determined using a drop of whole blood (15 &#x3bc;l) and the Urit 12 HB meter (URIT Medical Electronic Co. Ltd., China). Three 50 &#x3bc;l drops of whole blood were also spotted onto Whatmann #3 filter paper (GE Healthcare, USA). The remaining blood was separated into plasma and packed cells and each stored at &#x2212;20&#xb0;C.</p>
</sec>
<sec id="s2_2">
<title>Estimation of Parasite Density</title>
<p>The thick and thin blood smears were processed according to WHO guidelines (<xref ref-type="bibr" rid="B31">Organization, 2016</xref>) and as previously described (<xref ref-type="bibr" rid="B9">Amoah et&#xa0;al., 2019b</xref>). The smears were observed under 100&#xd7; oil immersion objectives by two independent trained microscopists and any inconsistency in deciding a positive or negative slide was settled by the reading of a third microscopist. Parasite density was estimated by multiplying the number of parasites counted per 200 white blood cells (WBCs) by 40 based on the assumption that 1 &#x3bc;l of blood contains 8,000 WBCs.</p>
</sec>
<sec id="s2_3">
<title>DNA Extraction</title>
<p>The Saponin/Chelex DNA extraction method was used as previously described (<xref ref-type="bibr" rid="B8">Amoah et&#xa0;al., 2018</xref>). Briefly, two 3 mm discs were punched out of the dried filter paper blood spot into a 1.5 ml Eppendorf tube. A measure of 1 ml solution of 1&#xd7; phosphate-buffered saline and 50 &#xb5;l of 10% saponin was added to each tube, vortexed, and kept overnight at 4&#xb0;C. The discs were washed twice with 1 ml phosphate-buffered saline and kept in 30 &#xb5;l of 20% chelex and 70 &#xb5;l of Dnase/Rnase water was incubated at 95&#xb0;C for 10 min with intermittent vortexing. Finally, the tubes were spun for 6 min at 13,000 rpm and the supernatant containing the extracted gDNA was transferred into a sterile 0.5 ml microfuge tube and preserved at &#x2212;20&#xb0;C.</p>
</sec>
<sec id="s2_4">
<title>Determination of <italic>P. falciparum</italic> by Polymerase Chain Reaction</title>
<p>Nested polymerase chain reaction, was used to amplify the 18S <italic>rRNA</italic> gene of <italic>P. falciparum</italic> as previously described (<xref ref-type="bibr" rid="B9">Amoah et&#xa0;al., 2019b</xref>). The Nest 1 reaction mixture contained 80 nM of primers (rPLU5/rPLU6), 5 &#x3bc;l DNA template, 1&#xd7; polymerase chain reaction buffer, 167 nM dNTPs, 2.5 mM MgCl<sub>2</sub>, and 1 U of OneTaq DNA polymerase, which totaled up to 15 &#x3bc;l mixture. The nest 2 reaction mixture contained 133.33 nM of primers (rFAL1/rFAL2) and 0.5 &#x3bc;l of the nest 1 product. The cycling conditions were set as follows; initial denaturation (95&#xb0;C for 5 min), then 35 cycles of denaturation at 94&#xb0;C for 30 s, annealing at 55 and 58&#xb0;C (for nest 1 and nest 2 respectively) for 1 min and an extension at 68&#xb0;C for 1 min with a final extension at 68&#xb0;C for 5 min. The nest 2 polymerase chain reaction products were gel electrophoresed and visualized using UV illumination.</p>
</sec>
<sec id="s2_5">
<title>Determination of IgG Levels by Indirect Enzyme-Linked Immuno-Sorbent Assay (ELISA)</title>
<p>The IgG levels were determined according to previously described protocols <xref ref-type="bibr" rid="B7">(Amoah et&#xa0;al., 2019a</xref>). The Pfs230 antigen used in this study was the prodomain, amino acid (aa) residues 443 to 590 while the Pfs48/45 antigen comprised of the C-terminal 6C region (aa 291&#x2013;428); both of which were expressed in <italic>Lactococcus lactis</italic> (<xref ref-type="bibr" rid="B3">Acquah et&#xa0;al., 2017</xref>). The negative control samples comprised of pooled plasma from malaria na&#xef;ve individuals. The plasma used for plotting the standard curve and the positive control sample comprised of pooled plasma from individuals who were previously identified as containing high levels of IgG against these two antigens (<xref ref-type="bibr" rid="B10">Arredondo et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B22">Jones et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">MacDonald et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B3">Acquah et&#xa0;al., 2017</xref>). The Maxisorp plates (Nunc, Thermo Fisher) were coated with 100 &#xb5;l of antigen (Pfs48/45 or Pfs230) diluted to 1 &#xb5;g/ml in carbonated buffer (pH of 9.2) and the plasma samples were diluted 1:200 in 1% skimmed milk in 1&#xd7; PBS containing 0.5% Tween 20. The rest of the procedure was followed through to the reading of the plates using the ELx808 plate reader (BioTek) set at 450 nm as previously described (<xref ref-type="bibr" rid="B7">Amoah et&#xa0;al., 2019a</xref>).</p>
</sec>
<sec id="s2_6">
<title>Determination of Relative Avidity by ELISA</title>
<p>The relative avidity of IgG in each sample was determined as previously described (<xref ref-type="bibr" rid="B7">Amoah et&#xa0;al., 2019a</xref>). A procedure similar to the ELISA described above was used with an extra step incorporated after the plasma incubation step. Briefly, each plasma sample was added to four wells of the plate, after the set incubation time of 1 h, a 100 &#x3bc;l solution of 2.4 M sodium thiocyanate was added to two of the four wells for 15 min. After this incubation step, the wells of the plates were washed and the procedure followed through with the secondary IgG incubation step to the stop reaction exactly as with the indirect ELISA described above.</p>
</sec>
<sec id="s2_7">
<title>Data Analysis</title>
<p>The OD values obtained from the plate reader were converted into weighted concentrations (wConcs) using ADAMSEL (Ed Remarque, BPRC). Graphs were plotted using GraphPad Prism version 6 and Microsoft Excel. The Kruskal&#x2013;Wallis test and Dunn&#x2019;s multiple comparison <italic>post-hoc</italic> tests were used to assess statistical significance between median values of quantitative data between age groups (overall, &#x2265;10 yrs and &lt;10 yrs) and time points (November 2017, January 2018, March 2018 and May 2018). Within-individual variation of the antibody and avidity levels across the study period was assessed with the Friedman test. Association between microscopic and submicroscopic <italic>P.&#xa0;falciparum</italic> prevalence was determined by chi-square test and correlation between IgG responses against Pfs230 and Pfs48/45 were determined using Spearman&#x2019;s rank correlation (using GraphPad version 6). Linear regression models were fitted for the avidity of antibody levels in the final visit (May 2018) using the number of infections by microscopy, PCR, or both as the predictor variables. The association of <italic>P. falciparum</italic> carriage in previous months with that of May and their corresponding odds ratio was also determined using Graphpad prism. Statistical significance was determined at <italic>P &lt;</italic>0.05. The relative avidity index (RAI) for Pfs230 IgG, Pfs48/45 IgG was calculated as the ratio of the IgG concentration of the sodium thiocyanate-treated sample to the IgG concentration of the corresponding untreated sample multiplied by 100.</p>
<p>Plasma samples were assigned seropositive for antibodies against an antigen if the concentration of the antibodies in the sample was greater than the average plus two times the standard deviation of that for the negative control sample (pooled malaria-na&#xef;ve plasma).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Clinical Characteristics of the Study Participants</title>
<p>The study recruited non-febrile school children aged from 6 to 12 years residing in the Simiw community in the Central Region of Ghana. A total of 84 children with a median (IQR) age of 9 (8&#x2013;11) years were recruited in November 2017 and followed until May 2018. A total of 43 of the children were below 10 years old. No significant differences were observed in the median haemoglobin levels (Kruskal&#x2013;Wallis statistic = 5.250, <italic>P</italic> = 0.1544) and temperature (Kruskal&#x2013;Wallis statistic = 5.966, test <italic>P</italic> = 0.1133) of the children at all the four-time points (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristic of the study participants.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">November 2017</th>
<th valign="top" align="center">January 2018</th>
<th valign="top" align="center">March 2018</th>
<th valign="top" align="center">May 2018</th>
<th valign="top" align="center">
<italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Number of children</td>
<td valign="top" align="center">84</td>
<td valign="top" align="center">84</td>
<td valign="top" align="center">84</td>
<td valign="top" align="center">84</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Children &lt;10 yrs</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Children &#x2265;10 yrs</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Hb (g/dl)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Median</td>
<td valign="top" align="center">11.35</td>
<td valign="top" align="center">11.50</td>
<td valign="top" align="center">11.60</td>
<td valign="top" align="center">11.60</td>
<td valign="top" align="center">0.1544</td>
</tr>
<tr>
<td valign="top" align="left">IQR</td>
<td valign="top" align="center">10.30&#x2013;12.20</td>
<td valign="top" align="center">10.70&#x2013;12.20</td>
<td valign="top" align="center">10.70&#x2013;12.30</td>
<td valign="top" align="center">10.80&#x2013;12.50</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" colspan="6" align="left">Temp (<sup>&#xb0;</sup>C)</td>
</tr>
<tr>
<td valign="top" align="left">Median</td>
<td valign="top" align="center">36.70</td>
<td valign="top" align="center">36.40</td>
<td valign="top" align="center">36.40</td>
<td valign="top" align="center">36.40</td>
<td valign="top" align="center">0.1133</td>
</tr>
<tr>
<td valign="top" align="left">IQR</td>
<td valign="top" align="center">36.13&#x2013;36.9</td>
<td valign="top" align="center">36.3&#x2013;36.8</td>
<td valign="top" align="center">36.10&#x2013;36.7</td>
<td valign="top" align="center">36.0&#x2013;36.70</td>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Hb, Hemoglobin, Temp, Temperature; IQR, Interquartile range; yrs, years.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Asexual parasite prevalence estimated by microscopy was highest in March 2018 (36.9%) and lowest (7.14%) in May 2018, with the highest and lowest median parasite densities detected in May 2018 and January 2018 respectively (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Parasite prevalence estimated by polymerase chain reaction was highest (74.4%) in May and lowest (27.3%) in January. Variation in asexual parasite density was not statistically significant over the four time points (<italic>P</italic> = 0.2303, Kruskal&#x2013;Wallis statistic = 4.305). None of the samples used in this study tested positive for gametocytes by microscopy (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>) at any time point. Parasite carriage in May was significantly associated with that of March (Fisher&#x2019;s exact text, p = 0.0118) with participants who carried parasites in March having odds of 5.3 of being infected in May (<xref ref-type="supplementary-material" rid="ST1">
<bold>Additional File 1</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>P<italic>. falciparum</italic> parasite density and prevalence by microscopy and polymerase chain reaction.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">November 2017</th>
<th valign="top" align="center">January 2018</th>
<th valign="top" align="center">March 2018</th>
<th valign="top" align="center">May 2018</th>
<th valign="top" align="center">
<italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Microscopy</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Median PD/&#xb5;l (IQR)</td>
<td valign="top" align="center">1040.0</td>
<td valign="top" align="center">280.0</td>
<td valign="top" align="center">880.0</td>
<td valign="top" align="center">1920.0</td>
<td valign="top" align="center">0.2303</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">(300.0&#x2013;4680)</td>
<td valign="top" align="center">(160.0&#x2013;360.0)</td>
<td valign="top" align="center">(400.0&#x2013;2440)</td>
<td valign="top" align="center">(80.0&#x2013;4330)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Asexual parasite prevalence (% (n/N))</td>
<td valign="top" align="center">26.2</td>
<td valign="top" align="center">8.3</td>
<td valign="top" align="center">36.9</td>
<td valign="top" align="center">7.14</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">(22/84)</td>
<td valign="top" align="center">(7/84)</td>
<td valign="top" align="center">(31/84)</td>
<td valign="top" align="center">(6/84)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Gametocyte prevalence (% (n/N))</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">(0/84)</td>
<td valign="top" align="center">(0/84)</td>
<td valign="top" align="center">(0/84)</td>
<td valign="top" align="center">(0/84)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Polymerase chain reaction</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Total parasite prevalence (% (n/N))</td>
<td valign="top" align="center">27.3</td>
<td valign="top" align="center">46.4</td>
<td valign="top" align="center">42.9</td>
<td valign="top" align="center">74.4</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">(23/84)</td>
<td valign="top" align="center">(39/84)</td>
<td valign="top" align="center">(36/84)</td>
<td valign="top" align="center">(60/84)</td>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>PD, Parasite density (reported per &#xb5;l blood); IQR, Interquartile range; n, number of samples confirmed positive for P. falciparum by polymerase chain reaction; N, total number of samples tested for polymerase chain reaction.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Dynamics of Antibody Responses Against Pfs48/45</title>
<p>The overall median IgG level against Pfs48/45 did not show statistically significant variation from November 2017 to March 2018. In May, however, overall anti-Pfs48/45 IgG levels increased significantly compared to all preceding months of the dry season assessed (p &lt;0.0001). The median Pfs48/45 IgG levels in both the young children (&lt;10 yrs) and older children (&#x2265;10 yrs) did not vary significantly from November 2017 to March 2018 except the period from January to March, where IgG levels of the young children decreased significantly (P = 0.867). In May, however, median anti-Pfs48/45 antibody levels increased significantly relative to March levels for both young children (P&lt;0.001) and older children (P&lt;0.01) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Between the two age groups, older children had higher antibody levels than younger children in only March 2018, the second half of the dry season, but statistically the same for the other months assessed.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Changes in Pfs48/45 IgG level <bold>(A)</bold> and avidity <bold>(B)</bold> in 43 children &lt;10 years and 41 children &#x2265;10 years over the dry season spanning November 2017 to May 2018. Yrs, years. The extent of statistically significant difference in measurements indicated by *, ** and *** represent P &lt;0.05, P &lt;0.01, and P &lt;0.001 respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-770821-g002.tif"/>
</fig>
<p>The median relative avidities of anti-Pfs48/45 IgG in all the study participants (overall and age stratified) did not vary statistically from November to January. In March 2018 however, median relative avidity increased significantly for all children (P &lt;0.001). Transitioning from March to May produced a significant decrease in the overall median relative avidities (P = 0.0292) although it was statistically unchanged for both the young children (P = 0.106) and older children (P = 0.103) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>) sub-groups. Anti-Pfs4845 antibody levels but not avidity correlated positively (r = 0.282, P = 0.0095) with age in only March, the end of the dry season (<xref ref-type="supplementary-material" rid="ST1">
<bold>Additional File 1</bold>
</xref>). Within individuals, both the level and relative avidity of anti-Pfs48/45 IgG varied significantly between the various time points (P &lt;0.0001 for both) (<xref ref-type="supplementary-material" rid="ST1">
<bold>Additional File 1</bold>
</xref>)</p>
</sec>
<sec id="s3_3">
<title>Dynamics of Antibody Responses Against Pfs230</title>
<p>The median levels of anti-Pfs230 antibodies of the overall participants significantly increased in March (P = 0.001) and in May (P = 0.0125). In younger children, median IgG levels against Pfs230 increased significantly in only May (P = 0.014). In older children, however, median anti-Pfs230 antibody levels had a statistically significant increase in March (P = 0.002) and remained the same in May (P = 0.250). Median antibody levels were higher for young children than older children in November 2017, the beginning of the first half of the dry season (P = 0.036), while the reverse occurred in March 2018 (P = 0.0007), close to the end of the second half of the dry season (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). There were no statistically significant differences in the median relative avidities for the participants as a whole across the four time points (P = 0.0673). The relative avidity of anti-Pfs230 IgG in older children (&gt;10 yrs) did not show any statistically significant variations (P = 0.325) over the duration of the study (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). In younger children (&lt;10 yrs) however, the median relative avidities of anti-Pfs230 IgG dropped significantly in May (P&#xa0;&lt;0.001), to values lower than recorded in the older children (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Similar to Pfs48/45, anti-Pfs230 antibody levels correlated positively with age (r = 0.358, P = 0.008) but the relative avidity did not. In May however, both the levels and relative avidities of IgG against Pfs230 were positively correlated (r = 0.225, P = 0.0397 and r = 0.236, P = 0.0305, respectively) with age. The anti-Pfs230 antibody levels and relative avidities also varied significantly within individual participants (P = 0.0049 and P = 0.026, respectively) (<xref ref-type="supplementary-material" rid="ST1">
<bold>Additional File 1</bold>
</xref>)</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Changes in Pfs230 IgG level <bold>(A)</bold> and avidity <bold>(B)</bold> in 43 children &lt;10 years and 41 children &#x2265;10 years over the dry season spanning November 2017 to May 2018. The extent of statistically significant difference in measurements indicated by *, ** and *** represent P &lt;0.05, P &lt;0.01, and P &lt;0.001 respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-770821-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Seroprevalence of Antibodies Against Pfs230 and Pfs48/45</title>
<p>Percentage seroprevalence of IgG antibodies against both Pfs48/5 and Pfs230 of all the participants had a similar trend, decreasing from the beginning of the dry season (November 2018) to the middle of the dry season (January) after which it increased again by the end of the dry season (March) and the early rainy season (May) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). The observed trend of overall seroprevalence for both antigens was similar to that of median parasite densities of participants. The percentage seroprevalence of both the younger children and older children categories followed the same trend as the overall participants. In November and January, younger children had a higher seroprevalence of IgG against both antigens than older children. In March and May, however, older children had a higher seroprevalence of antibodies against Pfs230 than the younger children. For anti-Pfs48/45 however, older children had a higher Percentage seroprevalence than younger children in only March (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Seroprevalence of IgG antibodies against Pfs230 and Pfs48/45. Immune responses of participants were considered seropositive when their antibody concentrations were higher than that of the average plus twice the standard deviation of the negative control sample&#x2019;s concentration.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-770821-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Dynamics of Antibody Responses in the Presence or Absence of Active <italic>P. falciparum</italic> Infection</title>
<p>In the overall dataset, anti-Pfs48/45 IgG levels were higher in children without active infections in November (P = 0.027) and January (p = 0.019). In March however, the IgG levels in children without active infections dropped to similar levels as children with active infections, whose IgG levels remained unchanged from November to March. In May, the early parts of the rainy season anti-Pfs48/45 IgG in both children with and without active infections rose significantly relative to March levels (P &lt;0.001 for both months) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Variations in of anti-Pfs48/45 IgG levels <bold>(A)</bold> and Relative avidities <bold>(B)</bold> in young children (&lt;10 years) and older children (&#x2265;10 years) with (positive polymerase chain reaction test result) and without (negative-polymerase chain reaction test result) active <italic>P. falciparum</italic> infections over the dry season from November 2017 to May 2018. The number above each of the aligned dot plots represents the number of individuals in the group. The extent of statistically significant difference in measurements indicated by *, ** and *** represent P &lt;0.05, P &lt;0.01, and P &lt;0.001 respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-770821-g005.tif"/>
</fig>
<p>Children with and without active infections had similar relative anti-Pfs48/45 IgG avidity at all assessed time points. The relative avidities were unchanged between November and January but increased significantly in March (P &lt;0.001) and remained at the same level in May (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>) for both children with and without active infection.</p>
<p>Each of the two age groups (children &lt;10 and &#x2265;10 yrs) were sub-grouped into those with active infections (parasites detected by polymerase chain reaction, PCR+) and those without active infections (no parasites detected by polymerase chain reaction, PCR&#x2212;) and their anti-Pfs48/45 and anti-Pfs230 IgG antibody levels and avidities compared. It was observed that the antibody responses (both IgG levels and avidities) in the two groups of children (with and without active infection) were similar throughout the study period except in January when the Pfs48/45 IgG levels of young children without active infections was higher than their counterparts with active infections (<italic>P</italic> = 0.0112) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). In May, when younger children without an active infection had higher relative avidity (P = 0.019) than older children with active infection (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
<p>Overall, children with active infections had similar anti-Pfs230 IgG levels as those without active infections at all-time points. Anti-Pfs230 IgG levels however increased in children without active infection from January, mid dry season, to March which is towards the end of the dry season. Children with active infections in May had higher anti-Pfs230 IgG levels than in March (P = 0.0041). Children with and without active infections had similar median relative avidities at all-time points in all children as a whole or in the two age categories (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). In March, older children (&#x2265;10 yrs) without active infections had significantly higher anti-Pfs230 IgG levels than their age mates with active infections (P = 0.040) and young children (&lt;10 yrs) with (<italic>P</italic> = 0.0003)) or without active infections (<italic>P</italic> = 0.00135) (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Variations in of anti-Pfs230 IgG levels <bold>(A)</bold> and Relative avidities <bold>(B)</bold> in young children (&lt;10 years) and older children (&#x2265;10 years) with (positive polymerase chain reaction test result) and without (negative-polymerase chain reaction test result) active <italic>P. falciparum</italic> infections over the dry season from November 2017 to May 2018. The number above each of the aligned dot plots represents the number of individuals in the group. The extent of statistically significant difference in measurements indicated by *, ** and *** represent P &lt;0.05, P &lt;0.01, and P &lt;0.001 respectively.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-770821-g006.tif"/>
</fig>
<p>In May, the median relative avidity of Pfs230 IgG in older children (&#x2265;10 yrs) without active infections was significantly higher (<italic>P</italic> = 0.0263) than in younger children &lt;10 yrs with active infections (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). Older children with active infection had significantly lower relative avidity of anti-Pfs230 IgG compared to their age mates without active infections (P = 0.0378) or young children with active infections (P = 0.0315) in January. In May, however, the median relative avidity of older children with active infections rose to that of older children without active infection whose median relative avidity was significantly higher than young children without active infection (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). The individual antibody levels and relative avidities used in this section can be found in <xref ref-type="supplementary-material" rid="ST1">
<bold>Additional File 1</bold>
</xref>. Regressional analyses showed that the number of times an individual tested positive for parasites by PCR or microscopy were not significant predictors of the antibody levels and avidities against the two antigens. Consequently, there was no statistical difference between the number of times a person had been infected during our visits and the anti-Pfs230 parasite and anti-Pfs48/45 antibody levels and avidity (<xref ref-type="supplementary-material" rid="ST1">
<bold>Additional Files 1 and 2</bold>
</xref>).</p>
</sec>
<sec id="s3_6">
<title>Association Between IgG Responses Against Pfs48/45 and Pfs230</title>
<p>In November, no correlation was identified between the measured IgG levels and avidity against Pfs48/45. Moderate and positive correlations were identified in January which changed to a weak inverse correlation in both March and May. All the correlations identified other than in November were significant.</p>
<p>Significant negative correlations existed between IgG levels and avidity against Pfs230 throughout the study period. The correlation was strong in the first half of the study period but weak towards the peak season (in the second half of the study period) (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Correlation between IgG level and avidity against Pfs230, Pfs48/45.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Pfs48/45 IgG (level <italic>vs</italic> avidity)</th>
<th valign="top" align="center">Pfs230 IgG (level <italic>vs</italic> avidity)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Nov.2017</td>
<td valign="top" align="center">R = 0.0251,</td>
<td valign="top" align="center">r = &#x2212;0.5287,</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">
<italic>P</italic> = 0.7999</td>
<td valign="top" align="center">
<italic>P &lt;</italic>0.0001</td>
</tr>
<tr>
<td valign="top" align="left">Jan.2018</td>
<td valign="top" align="center">r = 0.4175,</td>
<td valign="top" align="center">r = &#x2212;0.6911,</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">
<italic>P &lt;</italic>0.0001</td>
<td valign="top" align="center">
<italic>P &lt;</italic>0.0001</td>
</tr>
<tr>
<td valign="top" align="left">Mar.2018</td>
<td valign="top" align="center">r = &#x2212;0.2177,</td>
<td valign="top" align="center">r = &#x2212;0.1824,</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">
<italic>P</italic> = 0.0360</td>
<td valign="top" align="center">
<italic>P</italic> = 0.0800</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">May.2018</td>
<td valign="top" align="center">r = &#x2212;0.2609,</td>
<td valign="top" align="center">r = &#x2212;0.2405,</td>
</tr>
<tr>
<td valign="top" align="center">
<italic>P</italic> = 0.0081</td>
<td valign="top" align="center">
<italic>P</italic> = 0.0149</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>r, correlation coefficient; P, p-value; vs, versus.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Although there are numerous reports on the development of immunity against the disease-causing asexual <italic>P. falciparum</italic> parasite, relatively few reports have characterized the development of immunity against the sexual stages of <italic>P. falciparum</italic>. However, this knowledge can help improve the development of transmission-blocking vaccines to reduce malaria transmission. This study, for the first time, characterizes both quantity and quality of naturally acquired antibodies to both transmission-blocking vaccine candidates, Pfs230 and Pfs48/45 over the course of the dry season into the early rainy season.</p>
<p>This study was conducted at the end of the peak malaria season through to the beginning of the subsequent peak season, a period where there is a paucity of mosquito vectors (<xref ref-type="bibr" rid="B8">Amoah et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B7">Amoah et&#xa0;al., 2019a</xref>). The persistence of <italic>P. falciparum</italic> throughout the study period suggests that the possibly few mosquito vectors circulating during the off-peak season were able to sustain malaria transmission within the community. Carriage of <italic>P. falciparum</italic> can result in the development of anemia (<xref ref-type="bibr" rid="B16">Doolan et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B27">Magombedze et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B17">Epopa et&#xa0;al., 2019</xref>) however, most of the children in this study, despite harboring malaria had normal hemoglobin levels. This could however be because asymptomatic infections predominantly contain low parasite densities, which are less likely to result in anemia as compared with high parasite density infections (<xref ref-type="bibr" rid="B16">Doolan et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B27">Magombedze et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B17">Epopa et&#xa0;al., 2019</xref>).</p>
<p>IgG levels against both Pfs230 and Pfs48/45 were highest in May which is the beginning of the peak season. This observation was somewhat similar to our previous observation of higher anti-Pfs230 IgG levels in the peak season compared to the off-peak season and suggested an increased exposure to gametocytes compared to the preceding months assessed in this study (<xref ref-type="bibr" rid="B7">Amoah et&#xa0;al., 2019a</xref>). Although no gametocytes were identified by microscopy over the course of the study, the persistent replication of asexual parasites during the erythrocytic life cycle of the parasite is known to result in the production of low densities of gametocytes that are detectable by techniques with higher sensitivities than microscopy (<xref ref-type="bibr" rid="B5">Alano, 2007</xref>; <xref ref-type="bibr" rid="B34">Reuling et&#xa0;al., 2018</xref>). Prolonged exposure to submicroscopic gametocyte densities has previously been identified to induced antibody responses (<xref ref-type="bibr" rid="B18">Haldar &amp; Mohandas, 2009</xref>; <xref ref-type="bibr" rid="B7">Amoah et&#xa0;al., 2019a</xref>; <xref ref-type="bibr" rid="B30">Muthui et&#xa0;al., 2020</xref>). A previous report from a similarly high malaria transmission setting of southern Ghana identified a higher prevalence of submicroscopic gametocytes densities during the off-peak season compared with the peak season (<xref ref-type="bibr" rid="B11">Ayanful-Torgby et&#xa0;al., 2018</xref>).</p>
<p>The trends in the relative avidity of IgG responses against Pfs48/45 antigen observed in both young and older children (&lt;10 yrs or &#x2265;10 yrs) were similar to the trend of asexual parasite prevalence estimated by microscopy. This is similar to observations made for the relative avidities of antibodies against asexual parasite antigens, which are low in high transmission settings due to frequent exposure to highly diverse parasite strains (<xref ref-type="bibr" rid="B1">Abagna et&#xa0;al., 2018</xref>). However, for most malaria infections, gametocyte densities are significantly lower than those of the asexual parasite (<xref ref-type="bibr" rid="B5">Alano, 2007</xref>; <xref ref-type="bibr" rid="B34">Reuling et&#xa0;al., 2018</xref>) and as such the lower numbers and diversity of gametocytes in the high transmission setting may be responsible for the inverse relationship between the relative avidity of antibody responses against sexual stage antigens relative to asexual stage antigens. The similarity of the pattern of the percentage seroprevalence and median parasite densities suggests that the level of antibodies produced was proportional to the parasitemia of infection.</p>
<p>Participants, especially older children (10&#x2013;12 years old), with active infections generally showed a trend of lower antibody levels against both sexual stage antigens than those without active infection. This observation could be due to the concomitant large amounts of antibodies produced in response to recent past exposure to asexual and sexual stage parasites that are currently protecting against parasite infection. At the onset of the peak season (in May) the relative avidity of Pfs48/45 IgG in the young children (&lt;10 years) with active infections were significantly higher than that of the older children (&#x2265;10 years) with and without active infection. A possible explanation for this could be the increase in exposure to low-density gametocytes in younger children relative to older children as gametocyte carriage has been suggested to be more prevalent in young children relative to the older population (<xref ref-type="bibr" rid="B32">Ouedraogo et&#xa0;al., 2007</xref>). The relative IgG avidity against Pfs230 at a time point close to peak malaria season was observed to be significantly higher in older children (&#x2265;10 years) than in younger children (&lt;10 years), suggesting that age could have an impact on the avidity. This increase in IgG antibody avidity with the increase in age could be due to increased exposure to the same antigen and hence the tendency of IgG avidity to develop or have matured better in adulthood than in childhood as recently reported (<xref ref-type="bibr" rid="B39">Tassi Yunga et&#xa0;al., 2021</xref>). Lack of an association between the number of times a person had been infected with parasites during the follow-ups and antibody levels or avidities was not surprising as all microscopic infections determined contained only asexual parasites. Furthermore, most of the submicroscopic infections could contain only asexual forms of the parasite or gametocytes at thresholds not high enough to stimulate high levels of immune response.</p>
<p>The observed correlation between the level and relative avidity being positive for Pfs48/45 IgG but negative for that of Pfs230 IgG in November and January (early parts of the off-peak malaria season), could be suggestive of differences in decay kinetics associated with dynamic conformational flexibility (<xref ref-type="bibr" rid="B21">Huber, 1979</xref>; <xref ref-type="bibr" rid="B6">Amaral et&#xa0;al., 2017</xref>) of antibodies against both antigens, despite biological relatedness existing between both antigens and a half-life of about three months having been determined for their antibodies. The negative correlation observed between IgG levels and avidities against both Pfs230 and Pfs48/45 in the second half of the study period, towards the peak malaria season, could be due to the effect of an increase in the frequency and persistence of high diversity infections on IgG responses (IgG avidities and levels) towards the peak season relative to the beginning as well as during the off-peak season (<xref ref-type="bibr" rid="B37">Sondo et&#xa0;al., 2020</xref>). Consistent infections have also been suggested to impair antibody affinity maturation in germinal centers and result in the production of antibodies with low avidity (<xref ref-type="bibr" rid="B38">Ssewanyana et&#xa0;al., 2017</xref>). An earlier study conducted in southern Ghana also reported an inverse relation between Pfs48/45 IgG levels and avidity (<xref ref-type="bibr" rid="B7">Amoah et&#xa0;al., 2019a</xref>).</p>
<sec id="s4_1">
<title>Study Limitations</title>
<p>The quality of the antibodies against an antigen is determined by higher binding affinity as well as functionality. This study did not determine the functionality of the antibodies beyond determining the relative avidity index. Functional assays such as antibody-mediated complement lysis or Opsonic phagocytosis are important measures of antibody functionality. We could however not perform these assays due to limited funding. Furthermore, submicroscopic gametocyte densities, as well as the entomological inoculation rate during the period of the study, were also not determined. These could have provided additional measures of exposure rates as well as the risk of parasite infection due to gametocytes whose surface antigens were studied in the current study. However, studies have identified submicroscopic gametocyte densities in samples that were classified as negative for gametocytes by microscopy (<xref ref-type="bibr" rid="B36">Shekalaghe et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B24">Lamptey et&#xa0;al., 2018</xref>) as well as have identified a very low prevalence of mosquito vectors in the off-peak malaria season (<xref ref-type="bibr" rid="B27">Magombedze et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B17">Epopa et&#xa0;al., 2019</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>Conclusion</title>
<p>IgG responses against Pfs48/45 and Pfs230 antigens were higher at the end of the off-peak season compared to the beginning. The relative avidities of IgG responses against Pfs230 and Pfs48/45 were inversely correlated to their IgG levels from the middle to the end of the off-peak season.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The datasets used and/or analyzed during the current study are included in the article or <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Material</bold>
</xref>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by The Institutional Review Board (IRB) of the Noguchi Memorial Institute for Medical Research (NMIMR). Written informed consent to participate in this study was provided by the participant&#x2019;s legal guardian/next of kin.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author Contributions</title>
<p>LA designed the study. LA, FA, and FB performed the statistical analysis. ES and FB performed the experiments. EO and ES collected the samples. LA, D-OY, FA, EO, ES, and FB wrote and revised the final manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The principal researcher funded this work from personal funds.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors are grateful to all volunteers who participated in this study, the guardians of the children for granting consent as well as the teachers and staff of the Simiw M/A Basic school who helped in numerous ways to make this study a success. We also thank Mr. Jovis Williams for helping with the ELISA and Dickson Donu for helping with the polymerase chain reactions.</p>
</ack>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2021.770821/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2021.770821/full#supplementary-material</ext-link>
</p>
  <supplementary-material xlink:href="Image_1.jpeg" id="SF1" mimetype="image/jpeg"/>
  <supplementary-material xlink:href="Table_1.xlsx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<sec id="s13">
<title>Abbreviations</title>
<p>IgG, immunoglobulin G<bold>;</bold> PCR, polymerase chain reaction<bold>;</bold> HB, hemoglobin<bold>;</bold> aa, Amino Acid; DNA, Deoxyribonucleic acid; wConc, weighted concentration; PD, parasite density; RAI, relative avidity index; yrs, years.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abagna</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Acquah</surname> <given-names>F. K.</given-names>
</name>
<name>
<surname>Okonu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Aryee</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Theisen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Amoah</surname> <given-names>L. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Assessment of the Quality and Quantity of Naturally Induced Antibody Responses to EBA175RIII-V in Ghanaian Children Living in Two Communities With Varying Malaria Transmission Patterns</article-title>. <source>Malar. J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>14</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-017-2167-3</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acquah</surname> <given-names>F. K.</given-names>
</name>
<name>
<surname>Donu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bredu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Eyia-Ampah</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Amponsah</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Quartey</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Asymptomatic Carriage of Plasmodium Falciparum by Individuals With Variant Blood Groups and Haemoglobin Genotypes in Southern Ghana</article-title>. <source>Malar. J.</source> <volume>19</volume> (<issue>1</issue>), <fpage>217</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-020-03299-1</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acquah</surname> <given-names>F. K.</given-names>
</name>
<name>
<surname>Obboh</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Asare</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Boampong</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Nuvor</surname> <given-names>S. V.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>S. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Antibody Responses to Two New Lactococcus Lactis-Produced Recombinant Pfs48/45 and Pfs230 Proteins Increase With Age in Malaria Patients Living in the Central Region of Ghana</article-title>. <source>Malar. J.</source> <volume>16</volume> (<issue>1</issue>), <fpage>306</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-017-1955-0</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>D. T.</given-names>
</name>
<name>
<surname>Akhtar</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nazim</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Akter</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Uddin</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Antibody Avidity in Humoral Immune Responses in Bangladeshi Children and Adults Following Administration of an Oral Killed Cholera Vaccine</article-title>. <source>Clin. Vaccine Immunol.</source> <volume>20</volume> (<issue>10</issue>), <fpage>1541</fpage>&#x2013;<lpage>1548</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/cvi.00341-13</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alano</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Plasmodium Falciparum Gametocytes: Still Many Secrets of a Hidden Life</article-title>. <source>Mol. Microbiol.</source> <volume>66</volume> (<issue>2</issue>), <fpage>291</fpage>&#x2013;<lpage>302</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05904.x</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaral</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kokh</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Bomke</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wegener</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Buchstaller</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Eggenweiler</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Protein Conformational Flexibility Modulates Kinetics and Thermodynamics of Drug Binding</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <issue>1</issue>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-017-02258-w</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amoah</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Abagna</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Ayanful-Torgby</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Blankson</surname> <given-names>S. O.</given-names>
</name>
<name>
<surname>Aryee</surname> <given-names>N. A.</given-names>
</name>
</person-group> (<year>2019</year>a). <article-title>Diversity and Immune Responses Against Plasmodium Falciparum Gametocytes in non-Febrile School Children Living in Southern Ghana</article-title>. <source>Malar. J.</source> <volume>18</volume> (<issue>1</issue>), <fpage>265</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-019-2895-7</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amoah</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Acquah</surname> <given-names>F. K.</given-names>
</name>
<name>
<surname>Ayanful-Torgby</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Oppong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Abankwa</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Obboh</surname> <given-names>E. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Dynamics of Anti-MSP3 and Pfs230 Antibody Responses and Multiplicity of Infection in Asymptomatic Children From Southern Ghana</article-title>. <source>Parasit. Vectors</source> <volume>11</volume> (<issue>1</issue>), <elocation-id>13</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13071-017-2607-5</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amoah</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Donu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Abuaku</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ahorlu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Arhinful</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Afari</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>b). <article-title>Probing the Composition of Plasmodium Species Contained in Malaria Infections in the Eastern Region of Ghana</article-title>. <source>BMC Public Health</source> <volume>19</volume> (<issue>1</issue>), <fpage>1617</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12889-019-7989-1</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arredondo</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Takayama</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>MacDonald</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Aravind</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Structure of the Plasmodium 6-Cysteine S48/45 Domain</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>109</volume> (<issue>17</issue>), <fpage>6692</fpage>&#x2013;<lpage>6697</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1204363109</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayanful-Torgby</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Quashie</surname> <given-names>N. B.</given-names>
</name>
<name>
<surname>Boampong</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Williamson</surname> <given-names>K. C.</given-names>
</name>
<name>
<surname>Amoah</surname> <given-names>L. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Seasonal Variations in Plasmodium Falciparum Parasite Prevalence Assessed by Varying Diagnostic Tests in Asymptomatic Children in Southern Ghana</article-title>. <source>PloS One</source> <volume>13</volume> (<issue>6</issue>), <fpage>e0199172</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0199172</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachmann</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Kalinke</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Althage</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Freer</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Burkhart</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Roost</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>The Role of Antibody Concentration and Avidity in Antiviral Protection</article-title>. <source>Science</source> <volume>276</volume> (<issue>5321</issue>), <fpage>2024</fpage>&#x2013;<lpage>2027</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.276.5321.2024</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bousema</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Drakeley</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Sauerwein</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Sexual-Stage Antibody Responses to P. Falciparum in Endemic Populations</article-title>. <source>Curr. Mol. Med.</source> <volume>6</volume> (<issue>2</issue>), <fpage>223</fpage>&#x2013;<lpage>229</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/156652406776055140</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dodoo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Aikins</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kusi</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Lamptey</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Remarque</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Milligan</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Cohort Study of the Association of Antibody Levels to AMA1, MSP119, MSP3 and GLURP With Protection From Clinical Malaria in Ghanaian Children</article-title>. <source>Malar. J.</source> <volume>7</volume>, <elocation-id>142</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1475-2875-7-142</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doolan</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Doba&#xf1;o</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Baird</surname> <given-names>J. K. J. C. M. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Acquired Immunity to Malaria</article-title>. <source>Clin Microbiol Rev</source>. <volume>22</volume>, <issue>1</issue>, <fpage>13</fpage>&#x2013;<lpage>36</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00025-08</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epopa</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Collins</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>North</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Millogo</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Benedict</surname> <given-names>M. Q.</given-names>
</name>
<name>
<surname>Tripet</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Seasonal Malaria Vector and Transmission Dynamics in Western Burkina Faso</article-title>. <source>Malar. J.</source> <volume>18</volume> (<issue>1</issue>), <fpage>113</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-019-2747-5</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haldar</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Mohandas</surname> <given-names>N. J. A. E. P. B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Malaria, Erythrocytic Infection, and Anemia</article-title>. <source>Hematology Am. Soc. Hematol. Educ. Program.</source> <volume>2009</volume> (<issue>1</issue>), <fpage>87</fpage>&#x2013;<lpage>93</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/asheducation-2009.1.87</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Healer</surname> <given-names>J.</given-names>
</name>
<name>
<surname>McGuinness</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Carter</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Transmission-Blocking Immunity to Plasmodium Falciparum in Malaria-Immune Individuals is Associated With Antibodies to the Gamete Surface Protein Pfs230</article-title>. <source>Parasitology</source> <volume>119</volume> (<issue>Pt 5</issue>), <fpage>425</fpage>&#x2013;<lpage>433</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/s0031182099005041</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howitt</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Wilinski</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Llin&#xe1;s</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Templeton</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Dzikowski</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Deitsch</surname> <given-names>K. W.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Clonally Variant Gene Families in Plasmodium Falciparum Share a Common Activation Factor</article-title>. <source>Mol. Microbiol.</source> <volume>73</volume> (<issue>6</issue>), <fpage>1171</fpage>&#x2013;<lpage>1185</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06846.x</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huber</surname> <given-names>R. J. B. F. O. P.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Conformational Flexibility and its Functional Significance in Some Protein Molecules</article-title>. <source>MOSBACH</source>. <volume>30</volume>, <fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-642-81395-5_1</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Grignard</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nebie</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Chilongola</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Dodoo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Sauerwein</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Naturally Acquired Antibody Responses to Recombinant Pfs230 and Pfs48/45 Transmission Blocking Vaccine Candidates</article-title>. <source>J. Infect.</source> <volume>71</volume> (<issue>1</issue>), <fpage>117</fpage>&#x2013;<lpage>127</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jinf.2015.03.007</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ploton</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Koski</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Ann-Lobo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Contreras</surname> <given-names>C. J. I. O. P.</given-names>
</name>
<name>
<surname>VIII</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Malaria Transmission-Blocking Immunity</article-title>. <source>Immunobiology of Proteins and Peptides</source> VIII:<fpage>65</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4615-1891-4_8</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamptey</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ofori</surname> <given-names>M. F.</given-names>
</name>
<name>
<surname>Kusi</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Adu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Owusu-Yeboa</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kyei-Baafour</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The Prevalence of Submicroscopic Plasmodium Falciparum Gametocyte Carriage and Multiplicity of Infection in Children, Pregnant Women and Adults in a Low Malaria Transmission Area in Southern Ghana</article-title>. <source>Malar. J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>331</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12936-018-2479-y</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leoratti</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Durlacher</surname> <given-names>R. R.</given-names>
</name>
<name>
<surname>Lacerda</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Alecrim</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>A. W.</given-names>
</name>
<name>
<surname>Sanchez</surname> <given-names>M. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Pattern of Humoral Immune Response to Plasmodium Falciparum Blood Stages in Individuals Presenting Different Clinical Expressions of Malaria</article-title>. <source>Malar. J.</source> <volume>7</volume>, <elocation-id>186</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1475-2875-7-186</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Shimp</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Reiter</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Herrera</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Burkhardt</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium Falciparum Sexual Stage Protein Pfs230</article-title>. <source>J. Biol. Chem.</source> <volume>291</volume> (<issue>38</issue>), <fpage>19913</fpage>&#x2013;<lpage>19922</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M116.732305</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magombedze</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Ghani</surname> <given-names>A. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A Trade-Off Between Dry Season Survival Longevity and Wet Season High Net Reproduction can Explain the Persistence of Anopheles Mosquitoes</article-title>. <source>Parasit. Vectors</source> <volume>11</volume> (<issue>1</issue>), <fpage>576</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13071-018-3158-0</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayor</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Doba&#xf1;o</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Nhabomba</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Guinovart</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Jim&#xe9;nez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Manaca</surname> <given-names>M. N.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>IgM and IgG Against Plasmodium Falciparum Lysate as Surrogates of Malaria Exposure and Protection During Pregnancy</article-title>. <source>Malar. J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>182</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-018-2331-4</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murugan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Buchauer</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Triller</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kreschel</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Pidelaserra Mart&#xed;</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Clonal Selection Drives Protective Memory B Cell Responses in Controlled Human Malaria Infection</article-title>. <source>Sci. Immunol.</source> <volume>3</volume> (<issue>20</issue>), <elocation-id>eaap8029</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.aap8029</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthui</surname> <given-names>M. K.</given-names>
</name>
<name>
<surname>Kamau</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bousema</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Blagborough</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Bejon</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kapulu</surname> <given-names>M. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Corrigendum: Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African Falciparum Context: A Systematic Review and Meta-Analysis</article-title>. <source>Front. Immunol. 11</source> <volume>389</volume>, <elocation-id>389</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.00389</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Organization</surname> <given-names>W. H.</given-names>
</name>
</person-group> (<year>2016</year>). <source>Malaria Microscopy Quality Assurance Manual-Version 2</source>: <publisher-name>World Health Organization</publisher-name>. pp. <fpage>119</fpage>.</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouedraogo</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>P.</given-names>
</name>
<name>
<surname>de Kruijf</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nebie</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Verhave</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Cuzin-Ouattara</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Age-Dependent Distribution of Plasmodium Falciparum Gametocytes Quantified by Pfs25 Real-Time QT-NASBA in a Cross-Sectional Study in Burkina Faso</article-title>. <source>Am. J. Trop. Med. Hyg.</source> <volume>76</volume> (<issue>4</issue>), <fpage>626</fpage>&#x2013;<lpage>630</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4269/ajtmh.2007.76.6268</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Outchkourov</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Roeffen</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Kaan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Jansen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Luty</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Schuiffel</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Correctly Folded Pfs48/45 Protein of Plasmodium Falciparum Elicits Malaria Transmission-Blocking Immunity in Mice</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>105</volume> (<issue>11</issue>), <fpage>4301</fpage>&#x2013;<lpage>4305</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0800459105</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reuling</surname> <given-names>I. J.</given-names>
</name>
<name>
<surname>van de Schans</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Coffeng</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Lanke</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Meerstein-Kessel</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Graumans</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>A Randomized Feasibility Trial Comparing Four Antimalarial Drug Regimens to Induce Plasmodium Falciparum Gametocytemia in the Controlled Human Malaria Infection Model</article-title>. <source>Elife</source> <volume>7</volume>, <elocation-id>e31549</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.31549</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Green</surname> <given-names>T. D.</given-names>
</name>
<name>
<surname>Montefiori</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>H. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination With Gp120-C3d Fusion Proteins</article-title>. <source>AIDS Res. Hum. Retroviruses</source> <volume>17</volume> (<issue>9</issue>), <fpage>829</fpage>&#x2013;<lpage>835</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/088922201750252025</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shekalaghe</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Bousema</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Kunei</surname> <given-names>K. K.</given-names>
</name>
<name>
<surname>Lushino</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Masokoto</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Wolters</surname> <given-names>L. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Submicroscopic Plasmodium Falciparum Gametocyte Carriage is Common in an Area of Low and Seasonal Transmission in Tanzania</article-title>. <source>Trop. Med. Int. Health</source> <volume>12</volume> (<issue>4</issue>), <fpage>547</fpage>&#x2013;<lpage>553</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-3156.2007.01821.x</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sondo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Derra</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Rouamba</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nakanabo Diallo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Taconet</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kazienga</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Determinants of Plasmodium Falciparum Multiplicity of Infection and Genetic Diversity in Burkina Faso</article-title>. <source>Parasit. Vectors</source> <volume>13</volume> (<issue>1</issue>), <fpage>427</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13071-020-04302-z</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ssewanyana</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Arinaitwe</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Nankabirwa</surname> <given-names>J. I.</given-names>
</name>
<name>
<surname>Yeka</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sullivan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kamya</surname> <given-names>M. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Avidity of Anti-Malarial Antibodies Inversely Related to Transmission Intensity at Three Sites in Uganda</article-title>. <source>Malar. J.</source> <volume>16</volume> (<issue>1</issue>), <fpage>67</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-017-1721-3</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tassi Yunga</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bobbili</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Lloyd</surname> <given-names>Y. M.</given-names>
</name>
<name>
<surname>Antallan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Matsunaga</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Quakyi</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Does Antibody Avidity to Plasmodium Falciparum Merozoite Antigens Increase With Age in Individuals Living in Malaria-Endemic Areas</article-title>? <source>Immunity</source> <volume>89</volume> (<issue>6</issue>), <fpage>e00522</fpage>&#x2013;<lpage>e00520</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00522-20</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Harvey</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Meza</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Llanos</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Guzman</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gamboa</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Acceptability of a Herd Immunity-Focused, Transmission-Blocking Malaria Vaccine in Malaria-Endemic Communities in the Peruvian Amazon: An Exploratory Study</article-title>. <source>Malar. J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>179</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12936-018-2328-z</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williamson</surname> <given-names>K. C.</given-names>
</name>
<name>
<surname>Kaslow</surname> <given-names>D. C.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Strain Polymorphism of Plasmodium Falciparum Transmission-Blocking Target Antigen Pfs230</article-title>. <source>Mol. Biochem. Parasitol.</source> <volume>62</volume> (<issue>1</issue>), <fpage>125</fpage>&#x2013;<lpage>127</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0166-6851(93)90186-2</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zakeri</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Babaeekhou</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Mehrizi</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Abbasi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Djadid</surname> <given-names>N. D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Antibody Responses and Avidity of Naturally Acquired Anti-Plasmodium Vivax Duffy Binding Protein (PvDBP) Antibodies in Individuals From an Area With Unstable Malaria Transmission</article-title>. <source>Am. J. Trop. Med. Hyg.</source> <volume>84</volume> (<issue>6</issue>), <fpage>944</fpage>&#x2013;<lpage>950</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4269/ajtmh.2011.11-0001</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>